MENU
TERN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Terns Pharmaceuticals (TERN) Ownership - Who owns Terns Pharmaceuticals?
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
1065 East Hillsdale Boulevard
Phone
+1 650 525-5535
Employees
66
Web
https://www.ternspharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
602.95M
P/E Ratio
N/A
Total Cash
315.45M
Projected Growth
N/A
Total Debt
1.13M
Revenue
N/A
Risk (Beta)
-0.64
Dividend Yield
N/A
Total Cash/Share
3.60
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TERN
Capitalization
603M
P/E Ratio
N/A
Risk (Beta)
-0.64
Dividend Yield
N/A
Total Cash
315M
Total Cash/Share
3.60
Total Debt
1.13M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
305M
P/B Ratio
1.98
Cash Flow
N/A
Earnings
-1.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
24.70
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-105M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-33.28
Shares Held By Institutions
352M
Shares Outstanding - Current
87.5M
Total Liabilities
15.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
24.368
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TERN showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1065 East Hillsdale Boulevard
Phone
+1 650 525-5535
Employees
66
Web
https://www.ternspharma.com